Michael J Blaha1, Seamus P Whelton2, Mahmoud Al Rifai2, Zeina A Dardari2, Leslee J Shaw3, Mouaz H Al-Mallah4, Kuni Matsushita5, John A Rumberger6, Daniel S Berman7, Matthew J Budoff8, Michael D Miedema9, Khurram Nasir10. 1. Johns Hopkins Ciccarone Center for Prevention of Heart Disease, Baltimore, MD, United States. Electronic address: mblaha1@jhmi.edu. 2. Johns Hopkins Ciccarone Center for Prevention of Heart Disease, Baltimore, MD, United States. 3. Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States. 4. King Abdul-Aziz Cardiac Center, Riyadh, Saudi Arabia. 5. Department of Epidemiology, Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States. 6. Princeton Longevity Center, Princeton, NJ, United States. 7. Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, CA, United States. 8. Department of Medicine, Harbor UCLA Medical Center, Los Angeles, CA, United States. 9. Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, United States. 10. Johns Hopkins Ciccarone Center for Prevention of Heart Disease, Baltimore, MD, United States; Center for Prevention and Wellness, Baptist Health South Florida, Miami, FL, United States.
Abstract
BACKGROUND: Although coronary artery calcium (CAC) has been investigated for over two decades, there is very limited data on the association of CAC with cause of death. The CAC Consortium is a large ongoing multi-center observational cohort of individuals who underwent non-contrast cardiac-gated CAC testing and systematic, prospective, long-term follow-up for mortality with ascertainment of cause of death. METHODS: Four participating institutions from three states within the US (California, Minnesota, and Ohio) have contributed individual-level patient data to the CAC Consortium (spanning years 1991-2010). All CAC scans were clinically indicated and physician-referred in patients without a known history of coronary heart disease. Using strict inclusion and exclusion criteria to minimize missing data and to eliminate non-dedicated CAC scans (i.e. concomitant CT angiography), a sharply defined and well-characterized cohort of 66,636 patients was assembled. Mortality status was ascertained using the Social Security Administration Death Master File and a validated algorithm. In addition, death certificates were obtained from the National Death Index and categorized using ICD (International Classification of Diseases) codes into common causes of death. RESULTS: Mean patient age was 54 ± 11 years and the majority were male (67%). Prevalence of CVD risk factors was similar across sites and 55% had a <5% estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk. Approximately 45% had a Calcium score of 0 and 11% had an Agatston Score ≥400. Over a mean follow-up of 12 ± 4 years, there were 3158 deaths (4.15 per 1000 person-years). The majority of deaths were due to cancer (37%) and CVD (32%). Most CVD deaths were due to CHD (54%) followed by stroke (17%). In general, CAC score distributions were similar across sites, and there were similar cause of death patterns. CONCLUSIONS: The CAC Consortium is large and highly generalizable data set that is uniquely positioned to expand the understanding of CAC as a predictor of mortality risk across the spectrum of disease states, allowing innovative modeling of the competing risks of cardiovascular and non-cardiovascular death.
BACKGROUND: Although coronary artery calcium (CAC) has been investigated for over two decades, there is very limited data on the association of CAC with cause of death. The CAC Consortium is a large ongoing multi-center observational cohort of individuals who underwent non-contrast cardiac-gated CAC testing and systematic, prospective, long-term follow-up for mortality with ascertainment of cause of death. METHODS: Four participating institutions from three states within the US (California, Minnesota, and Ohio) have contributed individual-level patient data to the CAC Consortium (spanning years 1991-2010). All CAC scans were clinically indicated and physician-referred in patients without a known history of coronary heart disease. Using strict inclusion and exclusion criteria to minimize missing data and to eliminate non-dedicated CAC scans (i.e. concomitant CT angiography), a sharply defined and well-characterized cohort of 66,636 patients was assembled. Mortality status was ascertained using the Social Security Administration Death Master File and a validated algorithm. In addition, death certificates were obtained from the National Death Index and categorized using ICD (International Classification of Diseases) codes into common causes of death. RESULTS: Mean patient age was 54 ± 11 years and the majority were male (67%). Prevalence of CVD risk factors was similar across sites and 55% had a <5% estimated 10-year atherosclerotic cardiovascular disease (ASCVD) risk. Approximately 45% had a Calcium score of 0 and 11% had an Agatston Score ≥400. Over a mean follow-up of 12 ± 4 years, there were 3158 deaths (4.15 per 1000 person-years). The majority of deaths were due to cancer (37%) and CVD (32%). Most CVD deaths were due to CHD (54%) followed by stroke (17%). In general, CAC score distributions were similar across sites, and there were similar cause of death patterns. CONCLUSIONS: The CAC Consortium is large and highly generalizable data set that is uniquely positioned to expand the understanding of CAC as a predictor of mortality risk across the spectrum of disease states, allowing innovative modeling of the competing risks of cardiovascular and non-cardiovascular death.
Authors: Geoffrey H Tison; Mengye Guo; Michael J Blaha; Robyn L McClelland; Matthew A Allison; Moyses Szklo; Nathan D Wong; Roger S Blumenthal; Matthew J Budoff; Khurram Nasir Journal: J Cardiovasc Comput Tomogr Date: 2015-04-07
Authors: Michael J Blaha; Matthew J Budoff; Rajesh Tota-Maharaj; Zeina A Dardari; Nathan D Wong; Richard A Kronmal; John Eng; Wendy S Post; Roger S Blumenthal; Khurram Nasir Journal: JACC Cardiovasc Imaging Date: 2016-04-13
Authors: Mouaz H Al-Mallah; Steven J Keteyian; Clinton A Brawner; Seamus Whelton; Michael J Blaha Journal: Clin Cardiol Date: 2014-08 Impact factor: 2.882
Authors: Khurram Nasir; Jonathan Rubin; Michael J Blaha; Leslee J Shaw; Ron Blankstein; Juan J Rivera; Atif N Khan; Daniel Berman; Paolo Raggi; Tracy Callister; John A Rumberger; James Min; Steve R Jones; Roger S Blumenthal; Matthew J Budoff Journal: Circ Cardiovasc Imaging Date: 2012-06-19 Impact factor: 7.792
Authors: Rajesh Tota-Maharaj; Michael J Blaha; John W McEvoy; Roger S Blumenthal; Evan D Muse; Matthew J Budoff; Leslee J Shaw; Daniel S Berman; Jamal S Rana; John Rumberger; Tracy Callister; Juan Rivera; Arthur Agatston; Khurram Nasir Journal: Eur Heart J Date: 2012-07-26 Impact factor: 29.983
Authors: Seamus P Whelton; Michael G Silverman; John W McEvoy; Matthew J Budoff; Ron Blankstein; John Eng; Roger S Blumenthal; Moyses Szklo; Khurram Nasir; Michael J Blaha Journal: JACC Cardiovasc Imaging Date: 2015-11-11
Authors: Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal Journal: N Engl J Med Date: 2008-03-27 Impact factor: 91.245
Authors: Song S Mao; Raveen S Pal; Charles R McKay; Yan G Gao; Ambarish Gopal; Naser Ahmadi; Janis Child; Sivi Carson; Junichiro Takasu; Behnaz Sarlak; Daniel Bechmann; Matthew Jay Budoff Journal: J Comput Assist Tomogr Date: 2009 Mar-Apr Impact factor: 1.826
Authors: Ramzi Dudum; Omar Dzaye; Mohammadhassan Mirbolouk; Zeina A Dardari; Olusola A Orimoloye; Matthew J Budoff; Daniel S Berman; Alan Rozanski; Michael D Miedema; Khurram Nasir; John A Rumberger; Leslee Shaw; Seamus P Whelton; Garth Graham; Michael J Blaha Journal: J Cardiovasc Comput Tomogr Date: 2019-03-27
Authors: Leslee J Shaw; James K Min; Khurram Nasir; Joe X Xie; Daniel S Berman; Michael D Miedema; Seamus P Whelton; Zeina A Dardari; Alan Rozanski; John Rumberger; C Noel Bairey Merz; Mouaz H Al-Mallah; Matthew J Budoff; Michael J Blaha Journal: Eur Heart J Date: 2018-11-01 Impact factor: 29.983
Authors: Joseph C Jensen; Zeina A Dardari; Michael J Blaha; Susan White; Leslee J Shaw; John Rumberger; Alan Rozanski; Daniel S Berman; Matthew J Budoff; Khurram Nasir; Michael D Miedema Journal: Circ Cardiovasc Imaging Date: 2020-07-14 Impact factor: 7.792
Authors: Olusola A Orimoloye; Sandeep Banga; Zeina A Dardari; S M Iftekhar Uddin; Matthew J Budoff; Daniel S Berman; Alan Rozanski; Leslee J Shaw; John A Rumberger; Khurram Nasir; Michael D Miedema; Roger S Blumenthal; Michael J Blaha; Mohammadhassan Mirbolouk Journal: Coron Artery Dis Date: 2019-12 Impact factor: 1.439
Authors: Siegfried Adelhoefer; S M Iftekhar Uddin; Albert D Osei; Olufunmilayo H Obisesan; Michael J Blaha; Omar Dzaye Journal: Radiol Cardiothorac Imaging Date: 2020-12-17
Authors: Philip Greenland; Michael J Blaha; Matthew J Budoff; Raimund Erbel; Karol E Watson Journal: J Am Coll Cardiol Date: 2018-07-24 Impact factor: 24.094
Authors: S M Iftekhar Uddin; Mohammadhassan Mirbolouk; Sina Kianoush; Olusola A Orimoloye; Zeina Dardari; Seamus P Whelton; Michael D Miedema; Khurram Nasir; John A Rumberger; Leslee J Shaw; Daniel S Berman; Matthew J Budoff; John W McEvoy; Kunihiro Matsushita; Michael J Blaha; Garth Graham Journal: Hypertension Date: 2019-05 Impact factor: 10.190
Authors: Steven J Lahti; David I Feldman; Zeina Dardari; Mohammadhassan Mirbolouk; Olusola A Orimoloye; Albert D Osei; Garth Graham; John Rumberger; Leslee Shaw; Matthew J Budoff; Alan Rozanski; Michael D Miedema; Mouaz H Al-Mallah; Dan Berman; Khurram Nasir; Michael J Blaha Journal: Atherosclerosis Date: 2019-03-24 Impact factor: 5.162
Authors: Michael J Blaha; Miguel Cainzos-Achirica; Zeina Dardari; Ron Blankstein; Leslee J Shaw; Alan Rozanski; John A Rumberger; Omar Dzaye; Erin D Michos; Daniel S Berman; Matthew J Budoff; Michael D Miedema; Roger S Blumenthal; Khurram Nasir Journal: Atherosclerosis Date: 2019-11-16 Impact factor: 5.162
Authors: Nathan D Wong; Amber R Cordola Hsu; Alan Rozanski; Leslee J Shaw; Seamus P Whelton; Matthew J Budoff; Khurram Nasir; Michael D Miedema; John Rumberger; Michael J Blaha; Daniel S Berman Journal: Diabetes Care Date: 2020-08-17 Impact factor: 19.112